Status:

RECRUITING

Neural Enabled Prosthesis for Upper Limb Amputees

Lead Sponsor:

University of Arkansas, Fayetteville

Collaborating Sponsors:

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

United States Department of Defense

Conditions:

Amputation Arm and Hand, Unilateral Right

Amputation Arm and Hand, Unilateral Left

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is designed to evaluate the feasibility of The Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system.

Detailed Description

The purpose of this study is to evaluate a new prosthetic system for transradial amputees called the neural-enabled prosthetic hand (ANS-NEPH). It is intended to provide the sense of touch, grasp forc...

Eligibility Criteria

Inclusion

  • Unilateral transradial amputation
  • Amputation occurred 9 months ago or more
  • Functional hand contralateral to the amputation
  • Ability and willingness to use myoelectric arm (as determined by prosthetist)
  • 18 years of age or older
  • Ability to obtain transportation to the research site and the clinicians' offices
  • U.S. citizen or permanent U.S. resident
  • Signed the Informed Consent Form

Exclusion

  • Absence of limb due to birth defect
  • Evidence of denervation of the residual limb
  • Phantom limb pain that is severe enough to impair or restrict activity
  • Any neurological condition affecting motor and/or sensory function that would interfere with use of the intact hand or residual limb (as determined by neurologist)
  • Visual impairment that would affect hand usage during experimental procedures
  • History of chronic infections
  • History of recurring ulcers or blisters on the residual limb
  • Evidence of an active infection, non-healed ulcer, recent history of a healed ulcer (\< 3 months)
  • Use of another implanted electrical device (such as a pacemaker or nerve stimulator)
  • Undergoing diathermy therapy of the residual limb
  • History of non-compliance with medical or research procedures or any condition that would limit their ability to comply with study related procedures (self-reported)
  • Self-reported emotional or psychological disorders or history of drug or alcohol abuse or addiction
  • Memory disorders or significant cognitive impairment (self-reported and/or clinical observation during consent and screening procedures)
  • Moderate to severe chronic pain
  • Pregnant or nursing
  • Self-reported sensitivity to material derived from porcine source
  • Enrolled in another investigational research study
  • Any medical or psychiatric condition not otherwise specified (such as uncontrolled high blood pressure, heart or lung disease, active infection, and serious metabolic disorders) that would expose the subject to unacceptable risk and/or limit their ability to perceive meaningful sensation from stimulation of the peripheral nerves of the residual limb.

Key Trial Info

Start Date :

December 14 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT03432325

Start Date

December 14 2017

End Date

December 31 2025

Last Update

May 16 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Arkansas

Fayetteville, Arkansas, United States, 72701

2

Walter Reed National Military Medical Center

Bethesda, Maryland, United States, 20889-0001